Feb 28, 2017 21:06 pm UTC| Business
ENGLEWOOD, Colo., Feb. 28, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three and twelve months ended December 31, 2016. Ascent is a holding company that...
Feb 28, 2017 21:06 pm UTC| Business
ENGLEWOOD, Colo., Feb. 28, 2017 -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three and twelve months ended December 31, 2016. Ascent is a holding company that...
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Feb 28, 2017 21:06 pm UTC| Business
EMERYVILLE, Calif., Feb. 28, 2017 -- Adamas Pharmaceuticals,Inc. (Nasdaq:ADMS) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2016. “We expect 2017 to...
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Feb 28, 2017 21:06 pm UTC| Business
EMERYVILLE, Calif., Feb. 28, 2017 -- Adamas Pharmaceuticals,Inc. (Nasdaq:ADMS) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2016. “We expect 2017 to...
PRA Group Announces CEO Succession Plan
Feb 28, 2017 21:06 pm UTC| Business
Kevin Stevenson to become CEO following Annual Meeting in June 2017;Steve Fredrickson will become executive chairman of the PRA Board of Directors NORFOLK, Va., Feb. 28, 2017 -- PRA Group, Inc. (Nasdaq:PRAA), a global...
PRA Group Announces CEO Succession Plan
Feb 28, 2017 21:06 pm UTC| Business
Kevin Stevenson to become CEO following Annual Meeting in June 2017;Steve Fredrickson will become executive chairman of the PRA Board of Directors NORFOLK, Va., Feb. 28, 2017 -- PRA Group, Inc. (Nasdaq:PRAA), a global...
Otonomy to Present at Cowen and Company Health Care Conference
Feb 28, 2017 21:06 pm UTC| Business
SAN DIEGO, Feb. 28, 2017 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood